Incisive coverage of the issues important to vaping. Plus critical debate over the issues and impacts of regulation in both Canada and the U.S.
Episodes
Thursday Sep 02, 2021
Thursday Sep 02, 2021
It is a remarkable development in the contentious debate over nicotine vaping. A group of influential tobacco control experts authored a paper, published in The American Journal of Public Health, calling on the broader health community, policymakers, and the media to re-evaluate and reform their positions on vaping in favor of vaping as a tool for harm reduction
Joining us today on RegWatch is Dr. Robin J Mermelstein, Distinguished Prof. of Psychology and IHRP Director at the University of Illinois-Chicago, and Chair of FDA’s Tobacco Products Scientific Advisory Committee. Dr. Mermelstein is one of 15 past presidents of the prestigious Society for Research on Nicotine and Tobacco that coauthored the paper.
Why does this renowned group of anti-tobacco scientists advocate for greater adult access to nicotine vaping products? Find out.
Only on RegWatch by RegulatorWatch.com
Released: Sept 2, 2021
Produced by Brent Stafford
This episode is supported by DEMAND VAPE
*Support RegWatch - Go to https://support.regulatorwatch.com
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.